Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,042.15 UNCHANGED

Last Price Updated: 7:00 PM EST, Feb 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	1,043.05 (40)
Ask (Size)	1,043.90 (160)
Prev. Close	1,042.15
Today's Range	1,042.15 - 1,042.15
52wk Range	623.78 - 1,133.95
Shares Outstanding	956,580,893
Dividend Yield	0.58%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead? ↗

March 01, 2026

Eli Lilly is making headlines in the pharmaceutical sector, but it's a very expensive stock.

Via The Motley Fool

The Great Divergence: AI Supremacy Masks a Hidden Bear Market in Healthcare and Industrials

February 27, 2026

The final trading week of February 2026 has laid bare a striking fracture in the U.S. equity markets. While the technology sector continues to feast on a relentless AI-driven "execution" cycle, the...

Via MarketMinute

Performance

YTD	-3.5%	-3.5%
1 Month	-1.9%	-1.9%
3 Month	-6.1%	-6.1%
6 Month	+41.6%	+41.6%
1 Year	+18.2%	+18.2%

More News

The 7,800 Frontier: Morgan Stanley Flips the Script with Bullish S&P 500 Forecast

February 27, 2026

Via MarketMinute

The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan

February 27, 2026

Via MarketMinute

S&P 500 Crosses Historic 7,000 Milestone: Technical and Psychological Significance of the Breakout

February 27, 2026

Via MarketMinute

Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?

February 27, 2026

Via Barchart.com

The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026

February 27, 2026

Via Finterra

OPKO Health (OPK) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

The Great Recalibration: Investors Pivot from Silicon Dreams to Industrial Reality

February 26, 2026

Via MarketMinute

Forget Altimmune: This Proven Obesity‑Drug Giant Is the Better Weight‑Loss Play ↗

February 26, 2026

Via The Motley Fool

Why Shares of Novo Nordisk Stock Sank (Again) This Week ↗

February 26, 2026

Via The Motley Fool

Viking Therapeutics: The High-Stakes Weight Loss Contender ↗

February 26, 2026

Via MarketBeat

Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2 ↗

February 26, 2026

Via Benzinga

The Darwinian Transition: AI Monetization and Metabolic Mastery Define the Market’s New Frontier

February 26, 2026

Via MarketMinute

Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy

February 26, 2026

Via MarketMinute

Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026

February 26, 2026

Via Finterra

Alphabet Inc. (GOOGL) Deep Dive: Navigating the Agentic Era and the $180 Billion AI Bet

February 26, 2026

Via Finterra

Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore ↗

February 26, 2026

Via The Motley Fool

Eli Lilly’s Diabetes Pill Outperforms Oral Semaglutide in Phase 3 Trial ↗

February 26, 2026

Via Stocktwits

Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

February 25, 2026

Via StockStory

Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies ↗

February 25, 2026

Via The Motley Fool

Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics

February 25, 2026

Via MarketMinute

Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know. ↗

February 25, 2026

Via The Motley Fool

Labor Resilience Defies 'Soft Landing' Narrative: ADP Pulse Data Shows Four Weeks of Growth, Forcing Fed Rethink

February 25, 2026

Via MarketMinute

1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash ↗

February 25, 2026

Via The Motley Fool

Frequently Asked Questions

Is Eli Lilly publicly traded?

Yes, Eli Lilly is publicly traded.

What exchange does Eli Lilly trade on?

Eli Lilly trades on the New York Stock Exchange

What is the ticker symbol for Eli Lilly?

The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange

What is the current price of Eli Lilly?

The current price of Eli Lilly is 1,042.15

When was Eli Lilly last traded?

The last trade of Eli Lilly was at 02/24/26 07:00 PM ET

What is the market capitalization of Eli Lilly?

The market capitalization of Eli Lilly is 996.90B

How many shares of Eli Lilly are outstanding?

Eli Lilly has 997B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.